Skip to main content

Table 2 Odds ratio (95% CI) of developing breast cancer by category and 5% increase of EZH2 expression in epithelium or stroma in normal breast tissue

From: EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies

EZH2 expression

By category

Per 5% increase

 

≤10%

11–20%

>20%

P value for trend

 

P value

Epithelium

 Number of subjects (cases/controls)

48/184

10/55

16/30

 

74/269

 

  Model 1a

Ref.

0.70 (0.32–1.54)

2.44 (1.15–5.17)

0.078

1.17 (1.03–1.34)

0.021

  Model 2b

Ref.

0.73 (0.3–1.63)

2.67 (1.24–5.76)

0.053

1.20 (1.04– 1.38)

0.010

  Model 3c

Ref.

0.79 (0.32–1.96)

2.95 (1.1–7.84)

0.092

1.22 (1.02–1.46)

0.026

Stroma

 Number of subjects (cases/controls)

53/208

20/72

5/12

 

78/292

 

  Model 1a

Ref.

1.06 (0.58–1.96)

1.94 (0.62–6.07)

0.379

1.12 (0.93–1.35)

0.230

  Model 2b

Ref.

1.20 (0.6 –2.23)

2.13 (0.67–6.80)

0.227

1.15 (0.95–1.39)

0.147

  Model 3c

Ref.

1.32 (0.61–2.85)

2.45 (0.64–9.37)

0.189

1.18 (0.94–1.49)

0.157

  1. Matching factors: age at cancer diagnosis/index date, year of biopsy and, time between benign breast disease (BBD) biopsy and cancer diagnosis/index date. aModel 1: adjusting for matching factors. bModel 2: adjusting for matching factors and BBD category. cModel 3: adjusting for Model 2 + Ki67. EZH2 enhancer of zeste homolog 2, Ref. reference